Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I-II Study of Intratumoral Urelumab Combined With Nivolumab in Patients With Solid Tumors

NCT03792724 is registered in ClinicalTrials.gov with Clinica Universidad de Navarra, Universidad de Navarra as lead sponsor.

NCT NCT03792724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03792724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I-II Study of Intratumoral Urelumab Combined With Nivolumab in Patients With Solid Tumors
Lead sponsor
Clinica Universidad de Navarra, Universidad de Navarra
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 30, 2019
Completion date
January 30, 2023
Enrollment
32 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms